Victor V Uteshev
Overview
Explore the profile of Victor V Uteshev including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
517
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang H, Lin S, McElroy C, Wang B, Jin D, Uteshev V, et al.
Circ Res
. 2021 Aug;
129(7):e121-e140.
PMID: 34399581
[Figure: see text].
2.
Morales J, Young-Stubbs C, Shimoura C, Kem W, Uteshev V, Mathis K
Front Med (Lausanne)
. 2021 Apr;
8:642960.
PMID: 33928103
There is a critical need for safe treatment options to control inflammation in patients with systemic lupus erythematosus (SLE) since the inflammation contributes to morbidity and mortality in advanced disease....
3.
Gaidhani N, Tucci F, Kem W, Beaton G, Uteshev V
Br J Pharmacol
. 2021 Jan;
178(7):1684-1704.
PMID: 33496352
Background And Purpose: Targeting α7 nicotinic ACh receptors (nAChRs) in neuroinflammatory disorders including acute ischaemic stroke holds significant therapeutic promise. However, therapeutically relevant signalling mechanisms remain unidentified. Activation of neuronal...
4.
Gaidhani N, Kem W, Uteshev V
Brain Res
. 2020 Nov;
1751:147196.
PMID: 33159972
Acute ischemic stroke (AIS) causes both central and peripheral inflammation, while activation of α7 nicotinic acetylcholine receptors (nAChRs) provides both central and peripheral anti-inflammatory and anti-apoptotic effects. Here, we provide...
5.
Feng L, Uteshev V, Premkumar L
Int J Mol Sci
. 2019 Apr;
20(9).
PMID: 31027359
The nucleus of the solitary tract (NTS) receives visceral information via the solitary tract (ST) that comprises the sensory components of the cranial nerves VII, IX and X. The Transient...
6.
Gaidhani N, Uteshev V
Pharmacol Res
. 2018 Sep;
136:121-132.
PMID: 30205140
To minimize irreversible brain injury after acute ischemic stroke (AIS), the time to treatment (i.e., treatment delay) should be minimized. However, thus far, all cytoprotective clinical trials have failed. Analysis...
7.
Gaidhani N, Sun F, Schreihofer D, Uteshev V
Brain Res Bull
. 2017 Jul;
134:168-176.
PMID: 28755978
Tremendous efforts and funds invested in discovery of novel drug treatments for ischemic stroke have so far failed to deliver clinically efficacious therapies. The reasons for these failures are not...
8.
Lapchak P, Uteshev V
Transl Stroke Res
. 2017 Mar;
8(2):104-106.
PMID: 28251583
No abstract available.
9.
Szabo C, Patel M, Uteshev V
J Primatol
. 2016 Mar;
4(2).
PMID: 26924854
The baboon represents a natural model for genetic generalized epilepsy and sudden unexpected death in epilepsy (SUDEP). In this retrospective study, cerebrospinal fluid (CSF) monoamine metabolites and scalp electroencephalography (EEG)...
10.
Sun F, Johnson S, Jin K, Uteshev V
Mol Neurobiol
. 2016 Feb;
54(3):2045-2059.
PMID: 26910820
Most survivors of ischemic stroke remain physically disabled and require prolonged rehabilitation. However, some stroke victims achieve a full neurological recovery suggesting that the human brain can defend itself against...